Drug-Coated Balloons for Coronary Artery Disease
Why the study?
An update of previous recommendations was needed on the basis of recently published data regarding drug-coated balloons in coronary artery disease.
Design
Consensus group recommendations update
Authors
Discussion
Loading...
Member takes
Implication
Supports updated DCB use in ISR and small-vessel disease; extends prior consensus on indications and techniques.
Structured PICO
P
Population
Patients with coronary artery disease, including those with in-stent restenosis, de novo small-vessel disease, high bleeding risk, and other emerging indications.
I
Intervention
Drug-coated balloons (DCBs)
This consensus document provides updated recommendations for the use of drug-coated balloons in coronary artery disease, highlighting their established role in in-stent restenosis and emerging indications such as small-vessel disease.
Cite This Study
Jeger et al. (2020) studied this question.